DOI QR코드

DOI QR Code

광물성 분진 노출 이직노동자에서 만성폐쇄성폐질환과 호기응축액 중의 malondialdehyde 및 혈청 염증지표 간의 관련성

The Relationship between Malondialdehyde in Exhaled Breath Condensate and Inflammatory Markers in Serum and COPD in Retired Workers Exposed to Mineral Dust

  • 이종성 (근로복지공단 직업환경연구원) ;
  • 신재훈 (근로복지공단 직업환경연구원) ;
  • 백진이 (근로복지공단 직업환경연구원) ;
  • 최병순 (근로복지공단 직업환경연구원)
  • Lee, Jong Seong (Institute of Occupation and Environment, Korea Workers' Compensation & Welfare Service) ;
  • Shin, Jae Hoon (Institute of Occupation and Environment, Korea Workers' Compensation & Welfare Service) ;
  • Baek, Jin Ee (Institute of Occupation and Environment, Korea Workers' Compensation & Welfare Service) ;
  • Choi, Byung-Soon (Institute of Occupation and Environment, Korea Workers' Compensation & Welfare Service)
  • 투고 : 2019.07.29
  • 심사 : 2019.09.13
  • 발행 : 2019.09.30

초록

Objectives: Chronic obstructive pulmonary disease(COPD) is an important cause of mortality in workers exposed to hazardous dust, such as crystalline silica or coal, and COPD is related to inflammation and oxidative stress in the lung. The aim of this study was to evaluate the association of oxidative stress and inflammation to COPD in retired workers exposed to mineral dust. Methods: The levels of malondialdehyde(MDA) in EBC as biomarkers for oxidative stress and C-reactive protein(CRP) and lactate dehydrogenase(LD) as biomarkers for inflammation were measured in 107 male subjects(63 pneumoconiosis and 42 COPD subjects). Results: Mean levels of EBC MDA(2.03 nmol/L vs. 4.65 nmol/L, p=0.010) and serum LD(170.3 U/L vs. 185.9 U/L, p=0.022) were significantly higher in subjects with COPD, but mean levels of serum CRP(p=0.469) did not show a statistical difference between the study groups. Level of EBC MDA was negatively correlated with ${%}FEV_1$ predicted(r=-0.279, p=0.004) and ${%}FEV_1/FVC$ ratio(r=-0.397, p<0.001). Conclusions: These results suggest that EBC is a useful biological matrix for investigation of respiratory oxidative stress. High levels of EBC MDA and serum LD are related to COPD in retired workers exposed to mineral dust.

키워드

참고문헌

  1. Anderson SC & Cockayne S. Clinical chemistry: concepts and application. New York: McGraw-Hill Co.; 2003. P. 273-273
  2. Andreoli R, Manini P, Corradi M, Mutti A, Niessen WM. Determination of patterns of biologically relevant aldehydes in exhaled breath condensate of healthy subjects by liquid chromatography/atmospheric chemical ionization tandem mass spectrometry. Rapid Commun Mass Spectrom 2003;17(7):637-645 https://doi.org/10.1002/rcm.960
  3. Agusti A. Thomas a. Neff lecture. Chronic obstructive pulmonary disease - a systemic disease. Proc Am Thorac Soc 2006;3(6):478-481 https://doi.org/10.1513/pats.200603-058MS
  4. Barnes PJ. Mediators of chronic obstructive pulmonary disease. Pharmacol Rev 2004;56(4):515-548 https://doi.org/10.1124/pr.56.4.2
  5. Bartoli ML, Novelli F, Costa F, Malagrino L, Melosini L et al. Malondialdehyde in exhaled breath condensate as a marker of oxidative stress in different pulmonary diseases. Mediators Inflamm 2011;2011:891752 https://doi.org/10.1155/2011/891752
  6. Bergdahl IA, Tore'n K, Eriksson K, Hedlund U, Nilsson T et al. Increased mortality in COPD among construction workers exposed to inorganic dust. Eur Respir J 2004;23:402-406 https://doi.org/10.1183/09031936.04.00034304
  7. Castranova V. From coal mine dust to quartz: Mechanism of pulmonary pathology. Inhal Toxicol 2000;12(Suppl 3):7-14 https://doi.org/10.1080/08958378.2000.11463226
  8. Castranova V, Vallyathan V, Ramsey DM, McLaurin JL, Pack D et al. Augmentation of pulmonary reactions to quartz inhalation by trace amounts of ironcontaining particles. Environ Health Perspect 1997;105(suppl 5):1319-1324 https://doi.org/10.1289/ehp.97105s51319
  9. Chen YW, Leung JM, Sin DD. A systematic review of diagnostic biomarkers of COPD exacerbation. PLoS One 2016;11(7):e0158843 https://doi.org/10.1371/journal.pone.0158843
  10. Choi JK, Paek DM, Lee JO. Normal predictive values of spirometry in Korean population. Tuberc Respir Dis 2005;58(3):230-242 http://dx.doi.org/10.4046/trd.2005.58.3.230
  11. Cobben NA, Drent M, Schols AM, Lamers RJ, Wouster EF et al. Serum lactate dehydrogenase and its isoenzyme pattern in ex-coalminers. Respir Med 1997;91(10):616-623 PMID:9488895 https://doi.org/10.1016/S0954-6111(97)90008-1
  12. Coggon D & Anthony Newman TA. Coal mining and chronic obstructive pulmonary disease: a review of the evidence. Thorax 1998;53(5):398-407 https://doi.org/10.1136/thx.53.5.398
  13. Cohen RA, Patel A, Green FHY. Lung disease caused by exposure to coal mine and silica dust. Semin Respir Crit Care Med 2008;29(6):651-661 https://doi.org/10.1055/s-0028-1101275
  14. Corhay JL, Moermans C, Henket M, Nguyen Dang D, Duysinx B et al. Increased of exhaled breath condensate neutrophil chemotaxis in acute exacerbation of COPD. Respir Res 2014;15:115 https://doi.org/10.1186/ s12931-014-0115-0
  15. Corradi M, Folesani G, Andreoli R, Manini P, Bodini A et al. Aldehydes and glutathione in exhaled breath condensate of children with asthma exacerbation. Am J Respir Crit Care Med 2003;167(3):395-399 https://doi.org/10.1164/rccm.200206-507OC
  16. Corradi M, Pignatti P, Manini P, Andreoli R, Goldoni M et al. Comparison between exhaled and sputum oxidative stress biomarkers in chronic airway inflammation. Eur Respir J 2004;24(6):1011-1017 https://doi.org/10.1183/09031936.04.00002404
  17. Cui X, Gong J, Han H, He L, Teng Y et al. Relationship between free and total malondialdehyde, a wellestablished marker of oxidative stress, in various types of human biospecimens. J Thorac Dis. 2018;10(5):3088-3097 https://doi.org/10.21037/jtd.2018.05.92
  18. Drent M, Cobben NA, Henderson RF, Wouters EF, van Dieijen-Visser M. Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation. Eur Respir J 1996;9(8):1736-1742 PMID:8866602 https://doi.org/10.1183/09031936.96.09081736
  19. Fabbri LM & Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet 2007;370(9589):797-799 https://doi.org/10.1016/S0140-6736(07)61383-X
  20. Fernandez Rego G, Ocio Achaerandio G, Gonzalez Cuervo V, Rodriquez Menendez C, Martinez Gonezalez C et al. Presence of acute phase response in coal workers' pneumoconiosis. Br J Ind Med 1991; 48(3):193-195 https://doi.org/10.1136/oem.48.3.193
  21. Gan WQ, Man SFP, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004;59(7):574-580 https://doi.org/10.1136/thx.2003.019588
  22. Grob NM, Aytekin M, Dweik RA. Biomarkers in exhaled breath condensate: a review of collection, processing and analysis. J Breath Res 2008;2(3):037004 https://doi.org/10.1088/1752-7155/2/3/037004
  23. Gulumian M, Borm PJA, Vallyathan, Castranova V, Donaldson K et al. Mechanistically identified suitable biomarkers of exposure, effect, and susceptibility for silicosis and coal-worker's pneumoconiosis: a comprehensive review. J Toxicol Environ Health, Part B 2006;9(5):357-395 https://doi.org/10.1080/15287390500196537
  24. Gutteridge JMC. Lipid peroxidation and antioxidants as biomarkers of tissue damage. Clin Chem 1995;41(12 Pt 2):1819-1828 PMID:7497639 https://doi.org/10.1093/clinchem/41.12.1819
  25. Horvath I, Hunt J, Barnes PJ, Alving K, Antczak A et al(ATS/ERS Task Force on exhaled breath condensate). Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005;26(3):523-548 https://doi.org/10.1183/09031936.05.00029705
  26. Inonu H, Doruk S, Sahin S, Erkorkmaz U, Celik D et al. Oxidativestress levels in exhaled breath condensate associated with COPD and smoking. Respir Care 2012 Mar;57(3):413-419 https://doi.org/10.4187/respcare.01302
  27. International Labour Office (ILO). Guidelines for the use of the ILO international classification of radiographs of pneumoconiosis. Revised Edition 2000. 2002 (Occupational Safety and Health Series, No. 22.) Geneva, International Labor Organization
  28. Karadag F, Kirdar S, Karul AB, Ceylan E. The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease. Eur J Intern Med 2008;19(2):104-108 https://doi.org/10.1016/ j.ejim.2007.04.026
  29. Kirkham PA & Barnes PJ. Oxidative stress in COPD. Chest 2013;144(1):266-273 https://doi.org/10.1378/chest.12-2664
  30. Korean academy of tuberculosis and respiratory diseases (KATRD). Guideline for COPD and asthma. Seoul: Seoul Medcus; 2005. p26-27
  31. Kostikas K, Papatheodorou G, Psathakis K, Panagou P, Loukides S. Oxidative stress in expired breath condensate of patients with COPD. Chest 2003;124(4):1373-1380 https://doi.org/10.1378/chest.124.4.1373
  32. Lee JS, Shin JH, Baek JE, Jeong JY, Choi BS. Inflammation and Oxidative Stress as related to Airflow Limitation Severity in Retired Miners with Chronic Obstructive Pulmonary Disease. J Korean Soc Occup Environ Hyg 2019:29(2):251-258 http://dx.doi.org/10.15269/JKSOEH.2019.29.2.251
  33. Lee JS, Shin JH, Lee YU, Baek JE, Choi BS. The serum levels of LD and CRP in patients of coal workers'pneumoconiosis with chronic obstructive pulmonary disease. Korean J Clin Lab Sci 2017;49(3):214-219 https://doi.org/10.15324/kjcls.2017.49.3.214
  34. Lee JS, Shin JH, Hwang JH, Baek JE, Choi BS. Malondialdehyde and 3-nitrotyrosine in exhaled breath condensate in retired elderly coal miners with chronic obstructive pulmonary disease.Saf Health Work 2014;5(2):91-96 https://doi.org/10.1016/j.shaw.2014.03.001
  35. Lin JL & Thomas PS. Current perspectives of oxidative stress and its measurement in chronic obstructive pulmonary disease. COPD 2010;7(4):291-306 https://doi.org/10.3109/15412555.2010.496818
  36. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380(9859):2095-2128 https://doi.org/10.1016/S0140-6736(12)61728-0
  37. Meijers JM, Swaen GM, Slangen JJ. Mortality of Dutch coal miners in relation to pneumoconiosis, chronic obstructive pulmonary disease, and lung function. Occup Environ Med 1997;54(10):708-713 https://doi.org/10.1136/oem.54.10.708
  38. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A et al. Standardisation of spirometry. Eur Respir J 2005;26(2):319-338 https://doi.org/10.1183/09031936.05.00034805
  39. MOEL, Ministry of Employment and Labor. Act on the prevention of pneumoconiosis and protection, etc of workers suffering from pneumoconiosis. 2017.7.26. Available from: URL: http://law.go.kr/LSW/eng/engLsAstSc.do?enuId=1&dataCls=lsAstSc&cptOfiCd=1492000#cptOfi1492000
  40. Montuschi P. Exhaled breath condensate analysis in patients with COPD. ClinicaChimica Acta 2005;356(1-2):22-34 https://doi.org/10.1016/j.cccn.2005.01.012
  41. Pepys MB & Hirschfield GM. "C-reactive protein: a critical update". J Clin Invest 2003;111(12):1805-1812 https://doi.org/10.1172/JCI18921
  42. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA et al. Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176(6):532-555 https://doi.org/10.1164/rccm.200703-456SO
  43. Schins RPF &Borm PJA. Mechanisms and mediators in coal dust induced toxicity: A review. Am Occup Hyg 1999;43(1):7-33 https://doi.org/10.1016/s0003-4878(98)00069-6
  44. Strassmann R, Bausch B, Spaar A, Kleijnen J, Braendli O et al. Smoking cessation interventions in COPD: a network meta-analysis of randomised trials. Eur Respir J 2009;34(3):634-640 https://doi.org/10.1183/09031936.00167708
  45. Su B, Liu T, Fan H, Chen F, Ding H et al. Inflammatory markers and the risk of chronic obstructive pulmonary disease: A systematic review and meta-analysis. PLoS One 2016;11(4):e0150586 https://doi.org/10.1371/journal.pone.0150586
  46. Tkacova R, Kluchova Z, Joppa P, Petrasova D, Molcanyiova A. Systemic inflammation and systemic oxidative stress in patients with acute exacerbations of COPD. Respir Med 2007;101(8):1670-1676 https://doi.org/10.1016/j.rmed.2007.03.005